Newly defined strategy will extend the frontier for research-driven excellence in cancer care across all patients and across all communities Read More...
In a randomized, placebo-controlled trial, the drug improved outcomes in patients with heart failure and mildly reduced or preserved ejection fraction Read More...
A study led by Brigham researchers finds that measuring three modifiable factors together provided greater information on risk compared to any marker used alone; inflammation shown to be at least as important as cholesterol, yet rarely measured Read More...
